Verseon (LSE:VERS) Issuance of Stock : £8.42 Mil (TTM As of Jun. 2019)

View and export this data going back to 2015. Start your Free Trial

What is Verseon Issuance of Stock?

Verseon's Issuance of Stock for the six months ended in Jun. 2019 was £8.40 Mil.

Verseon's Issuance of Stock for the trailing twelve months (TTM) ended in Jun. 2019 was £8.42 Mil.

Verseon Issuance of Stock Historical Data

The historical data trend for Verseon's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verseon Issuance of Stock Chart

Verseon Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Issuance of Stock

Get a 7-Day Free Trial

1.91

62.11

0.03

0.02

Verseon Semi-Annual Data
	Dec11	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19
Issuance of Stock	Get a 7-Day Free Trial									0.01	0.01	-	0.02	8.40

Verseon Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Jun. 2019 adds up the semi-annually data reported by the company within the most recent 12 months, which was £8.42 Mil.

Verseon Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Verseon's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Verseon (LSE:VERS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (LSE:VERS) » Definitions » Issuance of Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

47071 Bayside Parkway, Fremont, CA, USA, 94538

Website

http://www.verseon.com

Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.